Magda Kondej, Tomasz M Wróbel, Katarzyna M Targowska-Duda, Antón Leandro Martínez, Oliwia Koszla, Piotr Stepnicki, Agata Zieba, Alba Paz, Olga Wronikowska-Denysiuk, Maria I Loza, Marián Castro, Agnieszka A Kaczor Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety ChemMedChem.2022 May 24;e202200238.DOI: 10.1002/cmdc.202200238. 5. ChemMedChem, Vol. 17, Núm. 15.

Oliwia Koszla 1, Przemyslaw Solek 2, Ewa Kedzierska 3, Piotr Listos 4, Marián Castro 5, Agnieszka A Kaczor 6 7 In vitro and in vivo evaluation of antioxidant and neuroprotective properties of antipsychotic D2AAK1 Neurochem Res. 2022 Jun;47(6):1778-1789. doi: 10.1007/s11064-022-03570-8. Epub 2022 Apr 5.2022 Jun 5;236:114354. doi: 10.1016/j.ejmech.2022.114354. Epub 2022 Apr 8.

Martínez, A.L., Brea, J., Castro, M., García, Á., Santamaría, E., Lestón, Ó., Loza, M.I. 1 An Experience of Using a Canvas-Based Template for Blended-Learning in a Master in Drug Discovery International Journal of Emerging Technologies in Learning. Vol. 17, Núm. 6, pp. 257-267. DOI: 10.3991/IJET.V17I06.28149.

Margherita Mastromarino, Mauro Niso, Carmen Abate, Ewgenij Proschak, Mariam Dubiel, Holger Stark, Marián Castro, Enza Lacivita, Marcello Leopoldo Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties Molecules. 2022 Feb 15;27(4):1297. DOI: 10.3390/molecules27041297.

Justyna Zuk, Damian Bartuzi, Andrea G Silva, Monika Pitucha, Oliwia Koszla, Tomasz M Wróbel, Dariusz Matosiuk, Marián Castro, Agnieszka A Kaczor Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications Pharmacol Rep. 2022 Apr;74(2):406-424. Epub 2022 Jan 22. DOI: 10.1007/s43440-021-00352-x.

Agnieszka A Kaczor, Katarzyna M Targowska-Duda, Piotr Stepnicki, Andrea G Silva, Oliwia Koszla, Ewa Kedzierska, Angelika Grudzinska, Marta Kruk-Slomka, Grazyna Biala, Marián Castro. N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: in vitro, in silico and in vivo evaluation of a multi-target ligand Neurochem Int. 2021 Mar 12. DOI: 10.1016/j.neuint.2021.105016

Enza Lacivita, Mauro Niso, Margherita Mastromarino, Andrea Garcia Silva, Cibell Resch, Andre Zeug, María I Loza, Marián Castro, Evgeni Ponimaskin, Marcello Leopoldo. Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder ACS Chem Neurosci. 2021 Apr 1. DOI: 10.1021/acschemneuro.0c00647

M Cimadevila, L Gómez-García, A L Martínez, A Iglesias, J López-Giménez, M Castro, M I Cadavid, M I Loza, J Brea. Essential Role of the C148-C227 Disulphide Bridge in the Human 5-HT 2A Homodimeric Receptor . Biochem Pharmacol. 2020 Jul;177:113985. DOI: 10.1016/j.bcp.2020.113985.

Agnieszka A Kaczor, Katarzyna M Targowska-Duda, Andrea G Silva, Magda Kondej, Grazyna Biala, Marián Castro. N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1 H-benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic. Biomolecules. 10 (2) 2020 Feb 24 DOI: 10.3390/biom10020349.

Andrea G Silva, Laura Vila, Patrice Marques, Laura Moreno, Mabel Loza, María-Jesús Sanz, Diego Cortes, Marián Castro, Nuria Cabedo. 1-(2'-Bromobenzyl)-6,7-dihydroxy- N-methyl-tetrahydroisoquinoline and 1,2-Demethyl-nuciferine as Agonists in Human D 2 Dopamine Receptors. J Nat Prod. 2020 Jan 24. DOI: 10.1021/acs.jnatprod.9b00921.

Samaridou E, Walgrave H, Salta E, Álvarez DM, Castro-López V, Loza M, Alonso MJ. Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases. Biomaterials. 2019 Feb. DOI: 10.1016/j.biomaterials.2019.119657.

Magli E, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Giordano F, Castro M, Brea J, Loza MI, Santagada V, Caliendo G, Fiorino F. New Serotoninergic Ligands Containing Indolic and Methyl Indolic Nuclei: Synthesis and in Vitro Pharmacological Evaluation. Med Chem. 2020;16(4):517-530.. DOI: 10.2174/1573406415666190613153220.

Kondej M, Wróbel TM, Silva AG, Stepnicki P, Koszla O, Kedzierska E, Bartyzel A, Biala G, Matosiuk D, Loza MI, Castro M, Kaczor AA. Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs. Eur J Med Chem. 2019 Oct 15. DOI: 10.1016/j.ejmech.2019.07.050. [Epub ahead of print]

Areias F, Correia C, Rocha A, Brea J, Castro M, Loza MI, Proença MF, Carvalho MA. 2-Aryladenine derivatives as a potent scaffold for A₁, A₃ and dual A₁ /A₃ adenosine receptor antagonists: Synthesis and structure-activity relationships. Bioorg Med Chem. 2019 Aug 15. DOI: 10.1016/j.bmc.2019.06.034. Epub 2019 Jun 20.

Bettencourt AP, Castro M, Silva JP, Fernandes F, Coutinho OP, Sousa MJ, Proenca MF, Areias FM. Phenolic Imidazole Derivatives with Dual Antioxidant/Antifungal Activity: Synthesis and Structure-Activity Relationship Med Chem. 2018 Oct 5. doi: 10.2174/1573406414666181005143431. [Epub ahead of print]

Bettencourt A, Castro M, Silva J, Fernandes F, Coutinho O, Sousa MJ, Proença MF, Areias F. New Nitrogen Compounds Coupled to Phenolic Units with Antioxidant and Antifungal Activities: Synthesis and Structure Activity Relationship Molecules. 2018 Oct 3;23(10). pii: E2530. doi: 10.3390/molecules23102530.

Kondej M, Bartyzel A, Pitucha M, Wróbel TM, Silva AG, Matosiuk D, Castro M, Kaczor AA. Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D² Receptor Ligand. Molecules. 2018 Sep 4;23(9). pii: E2249. doi: 10.3390/molecules23092249.

Iglesias A, Cimadevila M, la Fuente RA, Martí-Solano M, Cadavid MI, Castro M, Selent J, Loza MI, Brea J. Serotonin 2A receptor disulfide bridge integrity is crucial for ligand binding to different signalling states but not for its homodimerization. Eur J Pharmacol. 2017 Sep 9. pii: S0014-2999(17)30594-0. doi: 10.1016/j.ejphar.2017.09.011. [Epub ahead of print]

Azuaje J, López P, Iglesias A, de la Fuente RA, Pérez-Rubio JM, García D, Stepniewski TM, García-Mera X, Brea JM, Selent J, Pérez D, Castro M, Loza MI, Sotelo E. Development of Fluorescent Probes that Target Serotonin 5-HT2B Receptors. Sci Rep. 2017 Sep 7;7(1):10765. doi: 10.1038/s41598-017-11370-2.

Dominguez JL, Fernández-Nieto F, Brea JM, Catto M, Paleo MR, Castro M, Catto M, Paleo MR, Porto S, Sardina FJ, Castro M, Pisani L, Carotti A, Soto-Otero R, Méndez-Álvarez E, Villaverde MC, Sussman F. 8-Aminomethyl-7-hydroxy-4-methylcoumarins as Multitarget Leads for Alzheimer's Disease ChemistrySelect Volume 1, Issue 11, pages 2742–2749, July 16, 2016.

Kaczor AA, Silva AG, Loza MI, Kolb P, Castro M, Poso A. Structure-based virtual screening for dopamine D2 receptor ligands as potential antipsychotics. ChemMedChem. 11(7):718-29 (2016)

Kaczor AA, Targowska-Duda KM, Budzynska B, Biala G, Silva AG, Castro M. In vitro, molecular modeling and behavioral studies of '3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic. Neurochem Int. 96:84-99 (2016)

Bouzo-Lorenzo M, Santo-Zas I, Lodeiro M, Nogueiras R, Casanueva FF, Castro M, Pazos Y, Tobin AB, Butcher AJ, Camiña JP. Distinct phosphorylation sites on the ghrelin receptor, GHSR1a, establish a code that determines the functions of ß-arrestins. Sci Rep. 2016 Mar 3;6:22495. doi: 10.1038/srep22495.

Kucwaj-Brysz K, Warszycki D, Podlewska S, Witek J, Witek K, González Izquierdo A, Satala G, Loza MI, Lubelska A, Latacz G, Bojarski AJ, Castro M, Kiec-Kononowicz K, Handzlik J. Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation. Eur J Med Chem. 2016 Apr 13;112:258-69. doi: 10.1016/j.ejmech.2016.02.024

Hoffmann C, Castro M, Rinken A, Leurs R, Hill SJ, Vischer HF. Ligand Residence Time at GPCRs - Why We Should Take Our Time to Study It. Mol Pharmacol. 2015 Sep;88(3):552-60. doi: 10.1124/mol.115.099671.

Vischer HF, Castro M, Pin JP. G Protein-Coupled Receptor Multimers: A Question Still Open Despite the Use of Novel Approaches. Mol Pharmacol. 2015 Sep;88(3):561-71. doi: 10.1124/mol.115.099440

Domínguez J, Fernández-Nieto F, Castro M, Catto M, Paleo MR, Porto S, Sardina FJ, Brea J, Carotti A, Villaverde MC, Sussman F. Computer Aided Structure Based Design of Multitarget Leads for Alzheimers Disease J Chem Inf Model. 55(1):135-48 (2015)

Kaczor AA, Makarska-Bialokoz M, Selent J, de la Fuente RA, Marti-Solano M, Castro M. Application of BRET for Studying G Protein-Coupled Receptors. Mini-Rev Med Chem 2014;14(5):411-25. doi: 10.2174/1389557514666140428113708

Selent J, Marti-Solano M, Rodríguez J, Atanes P, Brea J, Castro M, Sanz F, Loza MI, Pastor M. Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles. Eur J Med Chem 2014;77:91-5. doi: 10.1016/j.ejmech.2014.02.058.

Atanes P, Lacivita , Rodríguez J, Brea J, Burgueño J, Vela JM, Cadavid MI, Loza MI, Leopoldo M, Castro M. The arylpiperazine derivatives N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide (LP-211) and N-benzyl-4-(2-diphenyl)-1-piperazinehexanamide (MEL-9) exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding. Pharmacology Research & Perspectives. 2013. doi: 10.1002/prp2.13.

Colas E, Muinelo L, Llaurado M, Monge M, Barbazan J, Gonzalez M, Schoumacher M, Alonso L, Pedrola N, Ertekin T, Ruiz A, Castellvi J, Doll A, Gil-Moreno A, Vazquez-Levin M, Lapyckyj L, Lopez-Lopez R, Robine S, Friederich E, Castro M, Reventos J, Vignjevic D, Abal M. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas. Oncogene. 2012;31(45):4778-88. doi:10.1038/onc.2011.632.

Areias F, Costa M, Castro M, Brea J, Gregori-Puigjané E, Proença MF, Mestres J, Loza MI. New chromene scaffolds for adenosine A(2A) receptors: Synthesis, pharmacology and structure-activity relationships. Eur J Med Chem. 2012;54:303-10. doi: 10.1016/j.ejmech.2012.05.009.

Costa M, Areias F, Castro M, Brea J, Loza MI, Proença F. Synthesis of novel chromene scaffolds for adenosine receptors. Org Biomol Chem. 2011;9(11):4242-9. doi: 10.1039/c1ob05305a.

Sussman F, Otero JM, Villaverde MC, Castro M, Domínguez JL, González-Louro L, Estévez RJ, Estévez JC. On a possible neutral charge state for the catalytic dyad in ß-secretase when bound to hydroxyethylene transition state analogue inhibitors. J Med Chem. 2011;54(8):3081-5. doi: 10.1021/jm101568y.

Jenkins L, Brea J, Smith NJ, Hudson BD, Reilly G, Bryant NJ, Castro M, Loza MI, Milligan G. Identification of novel, species selective agonists of the G protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα 13. Biochem J. 2010; 432:51–459. doi:10.1042/BJ20101287.

Varin T, Gutiérrez-de-Terán H, Castro M, Brea J, Fabis F, Dauphin F, Aqvist J, Lepailleur A, Perez P, Burgueño J, Vela JM, Loza MI, Rodrigo J. Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists. Br J Pharmacol. 2010;159(5):1069-81. doi: 10.1111/j.1476-5381.2009.00481.x.

Laguna R, Cadavid MI, Castro M, Brea JM, Loza MI. La experiencia de 10 años de docencia de la asignatura "Fuentes de Información Farmacológica de Medicamentos" impartida con el método de enseñanza basado en la resolución de problemas. Revista d'educació superior en Farmacia. 2009; nº 4. In Press

Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, Gardella TJ, Vilardaga JP. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol. 2009;5(10):734-42. doi:10.1038/nchembio.206.

Brea J, Castro M, Giraldo J, Lopez-Gimenez JF, Padin JF, Quintian F, Cadavid MI, Vilaro T, Mengod G, Berg KA, Clarke WP, Vilardaga JP, Milligan G, Loza MI. Evidence for distinct antagonist-revealed functional states of 5-HT2A receptor homodimers. Mol Pharmacol. 2009;75(6):1380-91. doi: 10.1124/mol.108.054395.

Buceta M, Dominguez E, Castro MA, Brea JM, Alvarez D, Barcala J, Valdés L, Alvarez-Calderón P, Domínguez F, Vidal B, Díaz JL, Miralpeix M, Beleta J, Cadavid MI, Loza MI. A new Chemicals tool (C0036E08) supports the role of adenosine A2B receptors in mediating human mast cell activation. Biochemical Pharmacology. 2008;76(7):912-21. doi: 10.1016/j.bcp.2008.07.011.

Domínguez E, Loza MI, Padín F, Gesteira A, Paz E, Páramo M, Brenlla J, Pumar E, Iglesias F, Cibeira A, Castro M, Caruncho H, Carracedo A, Costas J. Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population. Schizophrenia Research. 2007;90(1-3):123-9. doi: 10.1016/j.schres.2006.09.022

Padín JF, Rodríguez MA, Domínguez E, Dopeso-Reyes IG; Buceta M; Cano E; Sotelo E, Brea J, Caruncho HJ; Cadavid MI, Castro MA; Loza MI. Parallel regulation by olanzapine of the patterns of expression of 5-ht2a and d3 receptors in rat central nervous system and blood cells. Neuropharmacology. 2006;51(4):923-32. doi: 10.1016/j.neuropharm.2006.06.005

Brea J, Castro M, Loza MI, Masaguer CF, Ravina E, Dezi C, Pastor M, Sanz F, Cabrero-Castel A, Galan-Rodriguez B, Fernandez-Espejo E, Maldonado R, Robledo P. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Neuropharmacology. 2006;51(2):251-62. doi: 10.1016/j.neuropharm.2006.03.021

Castro M, Nikolaev VO, Palm D, Lohse MJ, Vilardaga JP. Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc Natl Acad Sci U S A. 2005;102(44):16084-9. doi: 10.1073/pnas.0503942102.

Panjehpour M, Castro M, Klotz KN. Human breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal. Br J Pharmacol. 2005;145(2):211-8. doi: 10.1038/sj.bjp.0706180.

Vilardaga JP, Bünemann M, Krasel C, Castro M, Lohse MJ. Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat Biotechnol. 2003;21(7):807-12. doi:10.1038/nbt838.

Castro M, Dicker F, Vilardaga JP, Krasel C, Bernhardt M, Lohse MJ. Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and beta-arrestins. Endocrinology. 2002;143(10):3854-65. doi: 10.1210/en.2002-220232.

Martínez-Torrecuadrada JL, Castón JR, Castro M, Carrascosa JL, Rodríguez JF, Casal JI. Different architectures in the assembly of infectious bursal disease virus capsid proteins expressed in insect cells. Virology. 2000 ;278(2):322-31. doi: 10.1006/viro.2000.0559.

Garzón J, Castro M, Sánchez-Blázquez P. Influence of Gz and Gi2 transducer proteins in the affinity of opioid agonists to mu receptors. Eur J Neurosci. 1998;10(8):2557-64. doi: 10.1046/j.1460-9568.1998.00267.x.

Sánchez-Blázquez P, Castro MA, Garzón J. Los receptores opioides mu y delta activan múltiples proteínas para producir analgesia supraespinal. Dolor. 1996; 11:69-75. Artículo de revisión)

Sánchez-Blázquez P, García-España A, Martín-Clemente B, Castro MA, Garzón J. Antisera to Galpha subunits of Gi and Gx/z transducer proteins impaired the supraspinal antinociceptive effect of neurotensin and clonidine in mice. Analgesia. 1996; 2:117-123. In press.

Garzón J, Juarros JL, Castro MA, Sánchez-Blázquez P. Antibodies to the cloned mu-opioid receptor detect various molecular weight forms in areas of mouse brain. Mol Pharmacol. 1995;47(4):738-44. In press.

Garzón J, Castro MA, Juarros JL, Sánchez-Blázquez P. Antibodies raised against the N-terminal sequence of delta opioid receptors blocked delta-mediated supraspinal antinociception in mice. Life Sci. 1994;54(11):PL191-6. In press.

Sánchez-Blázquez P, Juarros JL, Martínez-Peña Y, Castro MA, Garzón J. Gx/z and Gi2 transducer proteins on mu/delta opioid-mediated supraspinal antinociception. Life Sci. 1993;53(23):PL381-6. doi: 10.1016/0024-3205(93)90166-Z.